Amgen subsidiary deCODE Genetics has identified new risk factors and genes associated with clonal hematopoiesis, a precursor state to blood cancer. In the results of a study published Nov. 6 in Nature ...

In disease research, it's important to know gene expression and where in a tissue the expression is happening, but marrying the two sets of information can be challenging. "Single-cell technologies, ...

REYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and the USA published a study today in Nature ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in the understanding of genetic ...

Scientists at deCODE genetics, a subsidiary of AMGEN, have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson‘s ...

NEW YORK (CBS.MW) -- Shares of DeCode Genetics rose nearly 25 percent Tuesday after the company said it expanded a genetic research partnership with Switzerland's Roche AG. Financial terms weren't ...

A new study from deCODE genetics and Collaborators is the first to uncover a strong recessive component in Alzheimer’s disease. deCODE genetics/Amgen, and collaborators from Iceland, USA, UK, Denmark, ...

A new computational machine learning method developed by computational biologists can help researchers discover spatial patterns of gene expression in diseased tissue. In disease research, it's ...